Netherlands: revenue pharmaceutical care within health insurance 2008-2021

Between 2013 and 2020, the revenue of pharmaceutical care increased annually. In 2021, the total revenue of pharmaceutical care within the basic health insurance amounted to approximately 4.7 billion euros. This was an increase of 75 million euros compared to the previous year. Within the 2008 to 2021 period, the revenue of pharmaceutical care in the Netherlands peaked in 2011, at approximately five billion euros.

Pharmaceutical revenue within the basic health insurance package in the Netherlands from 2008 to 2021 (in million euros)

Characteristic	Revenue in million euros
2021	4,700
2020	4,625
2019	4,520
2018	4,438
2017	4,390
2016	4,335
2015	4,266
2014	4,128
2013	4,088
2012	4,398
2011	5,001
2010	4,923
2009	4,789
2008	4,742

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

August 2022

More information

Region

Netherlands

Survey time period

2008 to 2021

Supplementary notes

In the Netherlands, every resident or employee is obliged to take a basic health insurance to cover medical costs from, for example, visits to a general practitioner or the hospital. The Dutch government decides on the cover provided by this package and health insurance companies are obliged to accept everyone who meets the requirements, regardless of age or state of health. The numbers provided here concern pharmaceutical care as provided by public pharmacists.
* Provisional.

Citation formats